Table 2. Rheumatological work-up investigations.
ANA: antinuclear antibody, RA: rheumatoid arthritis, ANCA: anti-neutrophil cytoplasmic antibody, Anti-CCP: anti-cyclic citrullinated peptide.
| Name of the test | Case1 | Case2 | Case 3 | Normal range |
| ANA | 1:1280 | 1:320 | 1: 320 | <1:80 |
| Anti-ds DNA | 102.09 | 56.4 | 13.72 | <36 |
| Anti smith antoibody | Not done | >400 | Not done | <7 unit/ml |
| Serum C3 | 0.844 | 1.02 | 1.32 | 0.90-1.8 g/L |
| Serum C4 | 0.131 | 0.145 | 0.11 | 0.10-0.40 g/L |
| RA | 8 | 128 | 8 | <10 IU/mL |
| Anti-CCP | 10 | 1.48 | 10 | <50U/mL |
| c-ANCA | 3.58 | 1.5 | 1.4 | <5U/ml |
| p-ANCA | 2.50 | 1.4 | 1.4 | <5U/ml |
| Lupus Anti-coagulant | 1.18 | 1.18 | 1.18 | 0-1.20 |
| Anti-cardiolipin Ab Ig M and Ig G | 4.6 and 5.1 | 4.5 and 5.2 | 4.5 and 5 | <40 GPLU /ml |
| Anti-beta two glycoprotein IgM and Ig G | 2.8 and 3.9 | 5 and5.4 | 3 and 5 | <40 SGU U/ml |